8-K
filed June 22, 2026, 6:10 AM ET
ticker BGMS
CIK 0001130166
other
confidence high
sentiment neutral
materiality 0.15
Bio Green Med Solution (BGMS) annual meeting: two Class I directors elected, auditor ratified, exec comp approved
Bio Green Med Solution, Inc.
- Elected Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj as Class I directors, each receiving ~69% of votes cast.
- Ratified SFAI Malaysia Plt. as independent auditor for fiscal 2026 with 78.3% of votes in favor.
- Advisory vote on executive compensation approved with 68.9% support from shareholders.
- Annual meeting held on June 18, 2025; results reported in this 8-K filed June 22, 2026.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Bio Green Med Solution, Inc. shareholders approved Election of Class I Directors at the 2025-06-18 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2025-06-18
Exact text from the filing
Election of Directors : Our shareholders voted to elect the following individuals as Class I Directors, each of whom has been approved for re-election for a three-year term expiring at the 2029 annual meeting of stockholders: (a) Dr. Satis Waran Nair Krishnan, and (b) Inigo Angel Laurduraj.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Bio Green Med Solution, Inc. shareholders approved Approval of the Appointment of Auditors at the 2025-06-18 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2025-06-18
Exact text from the filing
Our shareholders ratified the appointment of SFAI Malaysia Plt. (PCAOB: 7167), as our independent auditors for the 2026 fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Bio Green Med Solution, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2025-06-18 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2025-06-18
Exact text from the filing
Approval by an Advisory Vote the Executive Compensation. Our shareholders approved, by an advisory vote, the compensation of our named executive officers and directors, as disclosed in this proxy statement.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.